Bladder cancer
INACTIVE --- It’s getting personalised: first-line therapy of synchronous or metachronous mUCa

Jonathan (73 years old)

Jonathan, 73 years old, is a retired cabinet maker. In his spare time, he is making a completely new furniture set for his daughter's living room.

He is diagnosed with metastatic urothelial bladder cancer during investigation of dysuria.

Assessment summary:

  • No relevant past medical history
  • CT scan of chest, abdomen and pelvis: diffuse liver and lung metastases
  • ECOG PS: 0
  • No peripheral neuropathy
  • No hearing impairment
  • Glomerular filtration rate (GFR): 90 ml/min
  • PD-L1 expression: strongly positive

Which treatment option would you choose for this patient?